According to the Association of the Electrical and Digital Industry, devices worth €12.1 billion were exported between January and August 2025. This represents growth of around eight percent compared to the same period last year. Companies generate more than seventy percent of their sales in Europe and other international markets, with the US remaining the most important single market.
A look at US tariffs shows how vulnerable global supply chains remain. Anticipatory effects following the announcement of higher tariffs initially led to additional exports, but in August, exports to the US slumped by almost thirty percent, according to the ZVEI. Other regions offset this decline, and the industry continues to grow.
“For us, this report sends a clear signal!”
Electromedical technology made in Germany is impressive and meets the high standards of quality, safety, and regulation. The pharmaceutical and medical technology dialogue initiated by the Chancellor’s Office also sets an example. In our view, reliable framework conditions and quick, robust decisions for development projects are crucial.
“We support our customers from the initial idea to the market-ready product, with mechanics, electronics, software, simulation, prototype construction, testing, and structured risk management. This results in devices that make everyday medical practice easier, meet regulatory requirements, and hold their own in international competition.”
We see the current figures as both a tailwind and a mandate. Electromedicine from Germany needs strong products, clear processes, and cooperative partnerships. That is what we focus our actions on.
